-+ 0.00%
-+ 0.00%
-+ 0.00%

Korro Bio Q4 EPS $(5.32) Misses $(2.05) Estimate, Sales $1.290M Beat $670.000K Estimate

Benzinga·03/12/2026 20:20:55
Listen to the news
Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(5.32) per share which missed the analyst consensus estimate of $(2.05) by 159.39 percent. This is a 135.4 percent decrease over losses of $(2.26) per share from the same period last year. The company reported quarterly sales of $1.290 million which beat the analyst consensus estimate of $670.000 thousand by 92.54 percent. This is a 43.20 percent decrease over sales of $2.271 million the same period last year.